260 related articles for article (PubMed ID: 32825138)
1. Merged Tacrine-Based, Multitarget-Directed Acetylcholinesterase Inhibitors 2015-Present: Synthesis and Biological Activity.
Eckroat TJ; Manross DL; Cowan SC
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825138
[TBL] [Abstract][Full Text] [Related]
2. Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments.
Bautista-Aguilera ÓM; Ismaili L; Iriepa I; Diez-Iriepa D; Chabchoub F; Marco-Contelles J; Pérez M
Chem Rec; 2021 Jan; 21(1):162-174. PubMed ID: 33169934
[TBL] [Abstract][Full Text] [Related]
3. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors.
Roldán-Peña JM; Romero-Real V; Hicke J; Maya I; Franconetti A; Lagunes I; Padrón JM; Petralla S; Poeta E; Naldi M; Bartolini M; Monti B; Bolognesi ML; López Ó; Fernández-Bolaños JG
Eur J Med Chem; 2019 Nov; 181():111550. PubMed ID: 31376562
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapy.
Dgachi Y; Martin H; Malek R; Jun D; Janockova J; Sepsova V; Soukup O; Iriepa I; Moraleda I; Maalej E; Carreiras MC; Refouvelet B; Chabchoub F; Marco-Contelles J; Ismaili L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):163-170. PubMed ID: 30482062
[TBL] [Abstract][Full Text] [Related]
5. A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors.
Pérez-Areales FJ; Turcu AL; Barniol-Xicota M; Pont C; Pivetta D; Espargaró A; Bartolini M; De Simone A; Andrisano V; Pérez B; Sabate R; Sureda FX; Vázquez S; Muñoz-Torrero D
Eur J Med Chem; 2019 Oct; 180():613-626. PubMed ID: 31351393
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, acetylcholinesterase inhibition and neuroprotective activity of new tacrine analogues.
León R; Marco-Contelles J; García AG; Villarroya M
Bioorg Med Chem; 2005 Feb; 13(4):1167-75. PubMed ID: 15670925
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional mercapto-tacrine derivatives for treatment of age-related neurodegenerative diseases.
Wang Y; Guan XL; Wu PF; Wang CM; Cao H; Li L; Guo XJ; Wang F; Xie N; Jiang FC; Chen JG
J Med Chem; 2012 Apr; 55(7):3588-92. PubMed ID: 22420827
[TBL] [Abstract][Full Text] [Related]
8. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
El-Malah A; Gedawy EM; Kassab AE; Salam RM
Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of New Tacrine Analogues under Microwave Irradiation.
Alshareef HF; Mohamed HAEH; Salaheldin AM
Chem Pharm Bull (Tokyo); 2017; 65(8):732-738. PubMed ID: 28768927
[TBL] [Abstract][Full Text] [Related]
10. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K
Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693
[TBL] [Abstract][Full Text] [Related]
11. Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§.
Milelli A; De Simone A; Ticchi N; Chen HH; Betari N; Andrisano V; Tumiatti V
Curr Med Chem; 2017; 24(32):3522-3546. PubMed ID: 28294041
[TBL] [Abstract][Full Text] [Related]
12. Bis(7)-tacrine derivatives as multitarget-directed ligands: Focus on anticholinesterase and antiamyloid activities.
Bolognesi ML; Bartolini M; Mancini F; Chiriano G; Ceccarini L; Rosini M; Milelli A; Tumiatti V; Andrisano V; Melchiorre C
ChemMedChem; 2010 Aug; 5(8):1215-20. PubMed ID: 20486153
[No Abstract] [Full Text] [Related]
13. Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Badia A; Baños JE; Camps P; Contreras J; Görbig DM; Muñoz-Torrero D; Simón M; Vivas NM
Bioorg Med Chem; 1998 Apr; 6(4):427-40. PubMed ID: 9597187
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
[TBL] [Abstract][Full Text] [Related]
15. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.
Wu WY; Dai YC; Li NG; Dong ZX; Gu T; Shi ZH; Xue X; Tang YP; Duan JA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):572-587. PubMed ID: 28133981
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues.
Marco JL; de los Ríos C; Carreiras MC; Baños JE; Badía A; Vivas NM
Bioorg Med Chem; 2001 Mar; 9(3):727-32. PubMed ID: 11310608
[TBL] [Abstract][Full Text] [Related]
17. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357
[TBL] [Abstract][Full Text] [Related]
18. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
20. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Edraki N; Sharifzadeh M; Khanavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():303-316. PubMed ID: 30396115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
